• Upcoding Part One: What is it and how common is it?

    Elsa Pearson is a senior policy analyst with Boston University School of Public Health. Follow her on Twitter: @epearsonbusph. Research for this piece was supported by the Laura and John Arnold Foundation.

    The complexity and opaqueness of health care billing seems to be an unfortunate given. Patients expect to be flummoxed by hospital bills and providers expect to fight to get reimbursed. Though this complexity, while frustrating, is not itself fraudulent, it provides the opportunity for more nefarious billing.

    Specifically, providers and payers can sometimes hide behind that complexity to intentionally bill erroneously. Upcoding is one potentially fraudulent form of billing. Upcoding occurs when more intensive and expensive diagnoses or treatments are documented than what was actually provided to the patient or medically necessary.

    Upcoding is happens and often. But before diving into the research, it is worth noting up front that not all billing investigations have found evidence of upcoding. Not every bill has been upcoded.

    For example, one study of anesthesia services reviewed almost 50,000 surgical records from patients aged 50 to 79 years with non-deferrable conditions, expecting to see upcoding trends in patient physical status scores (a measure of patient complexity). Because private insurers that serve the under-65 population pay higher rates than Medicare does for more complex patients, the authors hypothesized that providers would upcode more in younger patients. However, after conducting several regression analyses, they found no evidence of a statistically significant shift in physical status score at age 65, suggesting no upcoding in younger patients as a way to increase payment from private insurers. (Of course, their findings still do not rule out more general upcoding across the age gradient, independent of physical status scores and/or payer incentives.)

    Exceptions aside, research overwhelmingly suggests upcoding happens nationwide and often. Massachusetts recently found that a steady increase in coded patient acuity and patient risk scores contributed to higher state health care spending over the past few years. These increases could not be explained in totality by changes in actual patient demographics or disease prevalence, suggesting inappropriate upcoding rather than a true change in the patient population.

    Surgical specialties seem to be ripe for upcoding, perhaps given the number of unique services delivered and coded for in a finite period of time compared to nonsurgical specialties. A study of over 1.3 million gastroenterology surgeries completed from 2001 to 2011 analyzed the number of codes assigned to each admission. The authors found a systematic increase in the number of codes assigned to each case over time, even when they isolated only low risk patients (no comorbidities, elective procedures only). While the former may suggest simply more accurate coding practices, the latter suggests unnecessary upcoding given no available explanation due to patient complexity or disease severity.

    Another study of over one million gastroenterology procedures and their associated anesthesia services found that the number of patients with higher physical status scores increased by almost 8 percentage points from 2005 to 2013. The authors note this increase “cannot be explained by the severity of patients’ conditions… [nor by] changes in the physician population.”

    A 2018 NBER working paper found that Medicare Advantage upcoding costs taxpayers $2 billion a year. The authors noted that “the ‘coding inflation’ correlated with how closely tied the doctors were to the insurance plan, with the [coded] risk scores for enrollees in physician-owned plans 16 percent higher than otherwise would be expected.”

    ProPublica reported on an Inspector General report that found that Medicare overpaid $6.7 billion in upcoding in 2010 for evaluation and management clinic visits. What’s more, in a sub-analysis of Medicare claims, the Inspector General found that more than half of the claims were coded incorrectly. Nevertheless, the government said it wouldn’t investigate the physicians most responsible (those who upcode most often) given other active reviews.

    ProPublica also found that there are physicians who notoriously, and unnecessarily, bill for more complicated visits and treatments more frequently than their peers. For example, one physician coded and billed for the most complex type of office visit 95 percent of the time when his peers only did so about 5 percent of the time.

    Even in light of the evidence, it’s challenging to legally demonstrate that instances of upcoding are fraudulent. One JAMA commentary noted that proving coding fraud is difficult because of how the Centers for Medicare and Medicaid Services delineate fraud and abuse. One must prove intent to prove fraud; abuse is simply poor practice but not intentionally harmful.

    There can also be good, or acceptable, forms of aggressive coding that might be viewed as upcoding. This occurs when hospitals, providers, or insurance plans simply try to code and bill more accurately. The administrative burdens of health care are substantial and coding can easily become an afterthought, leading to inaccuracies. Simply addressing this is not necessarily bad, particularly if it aligns payment with actual patient need and complexity or intensity of services delivered. But it can be confused with fraudulent or abusive upcoding.

    For example, a lawsuit against the Baylor, Scott & White Health system that claimed the health system “inflated medical codes in order to maximize Medicare reimbursement” was recently defeated in court. The lawsuit argued upcoding between 2011 and 2017 led to $61.8 billion in false Medicare claims. But the court determined the health care system was simply implementing changes soon to be required by Medicare.

    The next post in this series will discuss what is being done to limit upcoding now and what else can be done in the future.

     
    item.php
  • The Opioid Crisis Continues

    In 2016, Healthcare Triage presented a special series of videos examining the opioid crises in the United States. Now, we’re taking another look at the crisis and seeing where we’ve improved, where we’ve failed, and what we can do better in the future. This first of four episodes will look at how the crisis has impacted the healthcare and foster care systems, the impact of changes in regulations, and where we are with regard to research and treatment.

     

    @DrTiff_PhD

     
    item.php
  • COVID-19 Update: August 10th Edition

    The following is a new contribution to the Baker Institute’s Weekly Covid-19 Blog by Vivian Ho, Ph.D. (@healthecontx), James A. Baker III Institute Chair in Health Economics, Kirstin Matthews, Ph.D. (@stpolicy), Baker Institute Fellow in Science and Technology Policy and Heidi Russell, M.D., Ph.D., Associate Professor, Department of Pediatrics, Baylor College of Medicine and Associate Director, Center for Medical Ethics and Health Policy, Baylor College of Medicine

    By the Numbers

    As of Friday, August 7, data from the Covid Tracking Project showed that the 7-day average (smoothed) number of new U.S. daily cases fell to 54,008, a 15% decrease relative to 63,240 the previous Friday. The smoothed percent of cases testing positive fell to 7.5% from 8.0% one week earlier. The smoothed number of deaths in the U.S. fell 5%, from 1113 one week earlier to 1053 last Friday. Here in Texas, the number of smoothed daily cases fell 2% between July 31 and August 7, while the smoothed number of daily deaths fell from 341 to 218. The smoothed percent of people testing positive rose from 10.3% on July 31st to 13.3% last Friday.

    Risk Factors and Disease Effects

    More than 107 million American adults are obese, and researchers are worried that a COVID-19 vaccine will be less effective for obese people. Vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies can be less effective in obese adults, who have weaker immune systems.

    Pakistan, with a population of 200 million, was down to 727 new cases on August 5th. Their success sharply contrasts with their neighbors Iran and India, which each are seeing 40,000 or 50,000 new cases each day and rising. The success is attributed to strong public health messaging.

    Health care workers of color were more likely to care for patients with suspected or confirmed COVID-19, more likely to report using inadequate or reused protective gear, and nearly twice as likely as white colleagues to test positive for the coronavirus, a new study from Harvard Medical School researchers found.

    A new study in JAMA Internal Medicine found that asymptomatic Covid-19 patients in Korea had similar viral loads as symptomatic patients. This finding indicates that asymptomatic people are likely to be infectious to others, which previously was believed based on anecdotal evidence.

    Researchers believe Covid-19 is unlikely to cause birth defects. However, doctors are still closely watching pregnancies of mothers-to-be that tested positive, especially if a woman tested positive early in the pregnancy.

    Vaccines and Treatments

    A Kaiser Health News story reports that thousands of people have volunteered for vaccine clinical trials, which will randomize them to receive an experimental vaccine or a placebo. Some test sites pay volunteers up to $2,000 for completing the two-year study. But a Wall Street Journal article reports that researchers worry the trials will enroll insufficient numbers of racial and ethnic minorities.

    Eli Lilly is using customized recreational vehicles to take an experimental antibody drug and personnel to U.S. nursing homes where a resident or staff member has Covid-19. Researchers will give the antibody by intravenous infusion to others at the nursing home who consent. Eli Lilly hopes to enroll 2,400 study subjects to test whether the drug reduces infection rates and disease in the weeks after dosing.

    Four former FDA commissioners endorsed The Fight Is In US, a broad coalition of public and private institutions working to recruit convalescent plasma donors across the country. However, researchers worry that the rush to treat patients with plasma is discouraging patients from enrolling in randomized clinical trials to confirm that the treatment is indeed effective.

    The Serum Institute, owned by the Pune family of India, produces 1.5 billion vaccine doses per year. The company has contracted with AstraZeneca to make 1 billion doses of the Oxford COVID-19 vaccine for India and lower- and middle-income countries, for which it will not charge above costs until the pandemic is over.

    Policy Interventions

    Seven governors have formed a purchasing compact they hope will induce companies that make rapid-detection tests to quickly ramp up production. Talks have begun with one of the two companies approved by the Food and Drug Administration to sell point-of-care antigen tests that can detect the virus in less than 30 minutes. Each state would request 500,000 tests, or 3.5 million in total.

    The US House Subcommittee on the Coronavirus Crisis held a congressional hearing to discuss the risks and benefits of opening schools to in-person teaching. A poll from the Kaiser Family Foundation found that the majority of parents supported postponing opening schools (to in-person teaching).

    A Food and Drug Administration effort to address a shortage of protective masks early in the pandemic has instead opened the floodgates to 3,500 Chinese manufacturers’ selling products of widely varying quality, potentially putting the public at risk and leaving some U.S. states with stockpiles of masks they no longer trust as protective gear.

    Signing Off

    This week marks the end of our weekly blog. The fall semester is rapidly approaching, and we must fully turn our attention to teaching and other academic duties.  We pooled our clinical and policy expertise to better understand the Covid-19 pandemic, and it’s been a privilege to share our findings with you. We are grateful for the continuing hard work and sacrifices of clinicians, scientists, and frontline workers around the world. We applaud experts Anthony Fauci, Deborah Birx, Scott Gottlieb, and others for continually offering thoughtful recommendations for controlling the U.S. pandemic. From them we have learned that the country does indeed have the resources to quell this virus, even before a vaccine arrives. Yet we suffer a lack of leadership at the national and state level, along with a corresponding epidemic of misinformation and mistrust. Things may worsen before they improve. But we have faith that progress will be made against Covid-19 in the coming months. We are returning to our efforts to identify strategies to increase access, lower costs, and improve the quality of care in a transformed post-pandemic healthcare system.

     
    item.php
  • Teaching Your Kids about Hand Hygiene

    Westyn Branch-Elliman, MD, MMSc is an Assistant Professor of Medicine at Harvard Medical School and a specialist in infectious diseases. She is formerly the Medical Director of Infection Control for the Eastern Colorado VA Healthcare System. She is a clinician investigator at the VA Center for Healthcare Organization and Implementation Research with expertise in epidemiology and implementation science. Her research is focused on measuring the risks and benefits of different infection prevention strategies and on expanding infection control beyond traditional inpatient settings. You can follow her on Twitter: @BranchWestyn

    One of the cornerstones of infection control is hand hygiene, but it can be challenging to impart to kids why it is important, and also how to perform hand hygiene most effectively. As a former hospital epidemiologist, promoting compliance with hand hygiene was one of the most important parts of my job: hand hygiene really does save lives.

    In my role as Medical Director of Infection Prevention, one of the strategies I found to be the most effective for showing the importance of basic hand hygiene was the “handprint” experiment. The basics are simple: make a handprint on one agar plate, then wash your hands, then make a handprint on another agar plate and compare them. The results of this experiment are usually dramatic—and can lead to a long-lasting memory about the effectiveness of hand hygiene among participants.

    Because of the effectiveness of this teaching method, I spent a long time thinking about how to translate it into an at-home or in-school experiment so that kids could also benefit from the visualization of seeing what is living on their hands (at least the bacteria), and how hand hygiene (either with sanitizer or soap and water) impacts bacterial growth, or the “germs living on your hands.” In thinking through how to do this myself, without the back up of a fully functioning microbiology laboratory, the biggest roadblock I encountered was the lack of an incubator—pretty much everything else is readily available on the web. My husband inadvertently solved that problem when he purchased himself a folding proofer for his bread making. One day, we were sitting in our kitchen and he was proofing his bread at a particularly high temperature. While he was programming the machine, I noted that his collapsible proofer could hold a temperature of at least 97 degrees for days at a time and I realized—much to my husband’s horror—I was finally in business.

    At the time I designed these teaching experiments (step-by-step instructions can be found here), my kids were in first and third grade, and so I tailored the teaching and the framing to different grade levels. I kept things simple for the younger kids, and just designed a simple pre-/post experiment with hand sanitizer (Option 1 in the step-by-step instructions).

    For the older kids, I tried to incorporate some teaching about the scientific method, including developing and testing a hypothesis (Option 2 in the step-by-step instructions). For this version, I split the class in two, with half of the students performing hand hygiene with soap and water, and half performing hand hygiene with hand sanitizer. Then, I asked the kids to make a prediction about which one would work better, and then we tested that prediction (they were surprised by what they found!).

    Our Real-World Findings:

    Their hypothesis was that soap and water would be superior to hand sanitizer.

    Some pictures of the paired hand sanitizer results:

    Note that there are many more little dots (e.g., different bacterial colonies) on the pre-plate than the post-plate. The number of different dots is what you (and the kids) should be looking for to measure efficacy. The post-plate does have one big circle, but that is just one large colony!

    This one (also a hand sanitizer example) is particularly good for demonstrating the difference between pre- and post hand hygiene:

    Here are a few more examples:

    These were some of the examples where you can really see that the hand hygiene worked, and the counters of the fingers on the “pre-plate.”

    Each kid in the class graded their own plates and we tallied the results as a group. Here are the approximate results:

    Being an epidemiologist, I actually calculated a p-value (using a chi-squared calculator to test the significance of the difference between pre and post in soap and water versus hand sanitizer): P= 0.046—statistically significant (which was a surprise—I did not expect it to be with such a small sample)!

    How We Interpreted the Results:

    We found that our hypothesis was incorrect: in our experiment, hand sanitizer appeared to be superior to soap and water hand washing. This is probably because sanitizer is more user-friendly. We find this pattern in other settings as well, and trials in schools have also suggested that sanitizer is probably better than soap and water. When thinking about infection control strategies, it is always important to think about practical issues and implementation outcomes!

    Closing Thoughts:

    There are lots of ways to do these experiments—these are a couple of designs that I hope will get you thinking about what you can do! For example, when I did the experiment with my son’s class, I did not include teaching on proper hand washing technique, because I wanted to demonstrate how well soap and water performed in real-world settings, and to compare that performance to the real-world performance of hand sanitizer. Teaching about how to do soap and water could certainly be incorporated into a slightly different design!

    Thank you!

    Thank you to Ms. Sarah Hammond and her third-grade class for participating in this experiment with me, and to Jasper for permitting me to share his results! I also need to thank my husband, for letting me use his bread proofer (I promise I fully disinfected it afterwards 😊).

     
    item.php
  • Reopening Schools in the Age of COVID

    School districts across the country are thinking about reopening. What is that going to look like? Can it be handled safely?

     

    @DrTiff_PhD

     
    item.php
  • Now more than ever, we need to do more for people experiencing homelessness

    Alane Celeste-Villalvir is a candidate for the Doctor of Public Health (DrPH) at the University of Texas Health Science Center at Houston (UTHealth) School of Public Health. She is currently a Health Policy Research Scholar, a program of The Robert Wood Johnson Foundation.

    The COVID-19 pandemic is challenging for all of us. It’s even more challenging if you’re a person experiencing homelessness. There are things Houston, and other cities, can do to make it better for them, and in doing so, for everyone.

    Staying safe during the COVID-19 pandemic is demanding for everyone. It requires regular hand washing, mask wearing, and maintaining physical distance from people who are sick. Many have had to juggle working from home while managing children, as well as being separate from friends, colleagues, and loved ones. And, the economic downturn has cost many jobs and health insurance.

    As hard as that is, the experience of COVID-19 for people who are homeless is even more challenging. When Texas’ stay-at-home order went into effect, Delandro (age 38) had no home to go to. A full-time student released from an 18-month recovery facility, he’s staying in his car and fighting against relapse. Like others experiencing homelessness, Delandro lacks a place to wash his hands and has difficulty managing acute and chronic disease, mental illness, and substance use disorders. Being homeless makes everything more difficult.

    Ada, a 51-year old woman living with throat cancer and experiencing homelessness shared that, “It’s even harder when just simple things like the use of a bathroom, you can’t have it,” she said. “And you can’t use a telephone. And you’re sleeping on concrete with open wounds.”

    The intersection of COVID-19 and homelessness is particularly acute for African Americans in Texas. Texas is among the states with the highest number of COVID-19 cases with 471,966 cases79,543 of which are in Harris County, where Houston is located. In Houston, African Americans make up 23% of the population but 66% of COVID-19 deaths. One reason is homelessness. More than half of Houston’s homeless population is African American.

    There are organizations to help people experiencing homelessness, but their resources have been stretched thin.

    Lord of the Streets (LOTS), a nonprofit serving people experiencing homelessness, has seen a spike in the need for food, as several Houston agencies have closed or changed their operations due to COVID-19. The demand for food has increased so much, that they served 333 meals in a single day in April, more than two times their normal level.

    Social services to alleviate hunger and food insecurity, like SNAP, can also help. But they’re not easy to access. “Food stamps were extended until the end of June, said Will Symmes, Director of Volunteers at LOTS. “But, if you are new, you had to do it via the phone. Well, not all homeless people have a phone.”

    Herman, who was seeking services at LOTS, reiterated the challenges with lacking access to technology. “You gotta have an appointment for everything. If you ain’t on the computer and you don’t know nothing about the online stuff, you gonna be in last place.”

    The Beacon, another community organization providing services to people experiencing homelessness, has also seen a spike in the need for services. It went from serving about 1500 meals a week to about 7700 meals a week. “The reason for that is because some of the other food service providers had to close or were very limited in what they were able to do for a period of time,” said Becky Landes, CEO of The Beacon.

    There’s more we could do. To improve the quality of life of people experiencing homelessness and lower their COVID-19 risk, cities must increase access to showers and other hygiene resources, safe places to sleep, and social services like SNAP. Homeless service providers must become hot spots for COVID-19 testing, with easy access to hand-washing stations, bathrooms, showers, food, and personal protective equipment.

    Many advocates recommend connecting people experiencing homelessness to housing as soon as possible, while also making other social services easily accessible — an approach known as “housing first.” In response to alarmingly high rates of COVID-19 infections in homeless shelters , cities such as New York and San Francisco have moved individuals from shelters to hotels. San Francisco has been sanctioning homeless encampments and labeling them as socially distant “Safe Sleeping Sites,” providing individuals with tents, showers, and other services. Similar programs have been implemented in Atlanta and West Virginia.

    In Houston, the Community-wide COVID-19 Housing Program, is a step in the right direction. This $65-billion collaborative effort between The City of Houston, Harris County, and Coalition for the Homeless plans to provide permanent housing to 5,000 individuals experiencing homelessness over the next two years in order to slow the spread of COVID-19.

    The challenges faced by people experiencing homelessness intensify the effects of the COVID-19 pandemic, which harms everyone. Flattening the curve demands that we not forget society’s most disenfranchised groups, including people experiencing homelessness. Now is not the time to back down in our fight against homelessness — we have to ramp it up. Protecting people experiencing homelessness both helps them and helps keeps us all safe.

    The opinions expressed by Alane Celeste-Villalvir are her own and do not represent those of University of Texas Health Science Center at Houston (UTHealth) School of Public Health. 

     
    item.php
  • COVID-19 Update: August 1st Edition

    The following is a new contribution to the Baker Institute’s Weekly Covid-19 Blog by Vivian Ho, Ph.D. (@healthecontx), James A. Baker III Institute Chair in Health Economics, Kirstin Matthews, Ph.D. (@stpolicy), Baker Institute Fellow in Science and Technology Policy and Heidi Russell, M.D., Ph.D., Associate Professor, Department of Pediatrics, Baylor College of Medicine and Associate Director, Center for Medical Ethics and Health Policy, Baylor College of Medicine

    By the Numbers

    As of Friday, July 31, data from the Covid Tracking Project showed that the 7-day average (smoothed) number of new U.S. daily cases fell to 63,240, a 5% decrease relative to 66,578 the previous Friday. The smoothed percent of cases testing positive fell to 8.0% from 8.4% one week earlier. The smoothed number of deaths in the U.S. rose 27%, from 876 a week earlier to 1113 last Friday. Here in Texas, the number of smoothed daily cases fell 13% between July 24 and July 31, while the smoothed number of daily deaths increased from 141 to 341. The smoothed percent of people testing positive fell from 11.2% on July 24th to 10.3% last Friday.

    Risk Factors and Disease Effects

    As of July 22, Texas has the highest percentage of COVID-19 deaths (30%) attributed to persons under age 65. In the state with the lowest share, Idaho, only 6% of COVID-19 deaths are in the under age 65 population.

    Scientific research has found that the coronavirus infects your nose first, using it as an entry point to the rest of your body and as a fertile hotspot for rapid replication. People who don’t cover their nose with their mask risk exposing their most infectious organ to others, and increase their own chances of contracting COVID-19.

    The New York Times reported on a JAMA Pediatrics finding that infected children have at least as much of the coronavirus in their noses and throats as infected adults. Children younger than age 5 may host up to 100 times as much of the virus in the upper respiratory tract as adults.

    A Reuters article summarized a CDC 13-state telephone survey of symptomatic adults with mild COVID-19 infections. The CDC found that about a fifth of patients under 35 years reported not returning to their usual state of health up to 21 days after testing positive.

    Antibody levels often drop so much two to three months after acute Covid-19 illness ends, that commercial tests don’t detect them. However, virtually everyone infected with the coronavirus seems to develop T-cells that learn to identify and destroy the virus, potentially preserving immunity. Yet T cells are harder to detect and therefore study.

    Pinewood Atlanta Studios, which filmed Avengers: Endgame, is testing all people on its studio lots at least weekly. The regime will cost $1.5m a month once cameras are rolling and several thousand workers are on set. Workers with high person-to-person contact are tested three times a week, and some actors prefer daily testing.

    Vaccines and Treatments

    The National Academy of Medicine, tasked by top U.S. health officials, named an expert panel to develop a framework to determine who should be vaccinated first when doses are scarce. But the Advisory Committee on Immunization Practices has made recommendations on vaccination policy to the Centers for Disease Control and Prevention for decades.

    French drug maker Sanofi said on Friday that it had secured an agreement of up to $2.1 billion to supply the U.S. federal government with 100 million doses of its experimental coronavirus vaccine. The Trump administration’s Operation Warp Speed has now committed over $8 billion, paying companies to manufacture millions of doses before clinical trials have been completed.

    Policy Interventions

    Both Dr. Anthony Fauci and Dr. Deborah Birx said in interviews this week that Americans searching for extra layers of protection against the coronavirus while out in public may want to try face shields.

    Some employers are requiring workers to sign a form agreeing not to sue the employer if the employee catches COVID-19 or suffers any injury from it while working. But lawyers who represent employers say that these waivers likely would be held unenforceable by courts, because of the unequal bargaining power between employers and employees.

     
    item.php